Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Edgar Kamantigue"'
Autor:
William Kwong, Ernie Hu, Franz Schweis, Anna Freed, Hua Yang, Chad L Fleischer, Brett Maroni, Jarrod Morgan, Steve Vaughn, Celina Puente, Edgar Kamantigue, Michael Reshatoff, Michael M. Becker, Alexis Zukowski, Robert Koehler, Kristin W. Livezey, Michele Wisniewski
Publikováno v:
Journal of AOAC INTERNATIONAL. 96:822-841
The Atlas™ Salmonella detection assay was compared to the reference culture methods for 12 foods and three surfaces. Comparison of the Atlas method to the U.S. Food and Drug Administration Bacteriological Analytical Manual (FDA/BAM) and U.S. Depart
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c645743a8713aad61f27783e9920d441
https://doi.org/10.5740/jaoacint.12-324
https://doi.org/10.5740/jaoacint.12-324
Autor:
Nancy Sajjadi, Tammi Howard, Wilson Edwards, Doug J. Jolly, Edgar Kamantigue, Steven Mento, Sunil Chada
Publikováno v:
Human Gene Therapy. 5:693-699
A murine retroviral vector encoding the human immunodeficiency virus type 1 (HIV-1) env and rev genes can be used to induce cytotoxic T lymphocyte responses. Immune responses can be induced by an ex vivo treatment, in which autologous cells are trans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95683bff181578f2e36f8d6d4e26c8a4
https://doi.org/10.1089/hum.1994.5.6-693
https://doi.org/10.1089/hum.1994.5.6-693
Autor:
Dale E. Johnson, William G. Glass, Judith Greengard, Martin Giedlin, Edgar Kamantigue, Martha E. I. Leibbrandt, Kim Boekelheide, Douglas J. Jolly, Nancy Sajjadi, Holger Roehl
Publikováno v:
Human gene therapy. 11(18)
In a phase 1 clinical trial, we are evaluating a murine leukemia virus (MuLV)-based retroviral vector encoding the human factor VIII gene [hFVIII(V)], administered intravenously, as a therapy for hemophilia A. Preclinical biolocalization studies in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47000b119bfb93d18e77b26e73d4c1f7
https://pubmed.ncbi.nlm.nih.gov/11119423
https://pubmed.ncbi.nlm.nih.gov/11119423
Autor:
James Hanlon, James E. McCormack, Edgar Kamantigue, Mary Petrowski, Steven J. Mento, Nancy Sajjadi, Douglas J. Jolly, Nicholas J. DePolo, Darlene Martineau, Wolfgang M. Klump
Publikováno v:
Human gene therapy. 8(10)
Gene delivery via murine-based recombinant retroviral vectors is currently widely used in gene therapy clinical trials. The vectors are engineered to be replication defective by replacing the structural and nonstructural genes of a cloned infectious
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03a29a861bf6164216646f2109b81f42
https://pubmed.ncbi.nlm.nih.gov/9215740
https://pubmed.ncbi.nlm.nih.gov/9215740